Faruk Örge, MD

Medical Advisory Board

Dr. Faruk H. Örge MD, FAAO, FAAP, is the William R. and Margaret E. Althans Chair and Professor in Pediatric Ophthalmology, Professor of Ophthalmology and Pediatrics at CWRU and Director of Pediatric Ophthalmology and Adult Strabismus at the Rainbow Babies and Children’s Hospital, one of the few pediatric hospitals ranked by US News and World Report. After completing a two-year research fellowship, internship, residency, and a clinical fellowship at Indiana University, Dr. Örge returned to his native country, Turkey, to join the faculty at Yeditepe University. He has been at RBCH since 2007.

Dr. Örge is widely recognized for his clinical expertise and is listed in the Best Doctors of America (since 2009), Top Doctors (since 2011), and Who’s Who (2014). Dr. Örge has served on and lead many committees (Online, Public Education, Program committees) of the American Association of Pediatric Ophthalmology and has joined the AAPOS Board of Directors in 2018 as a Director at Large. He is an examiner for the American Board of Ophthalmology and serves as the AAPOS liaison to the ABO. He is currently the Fellowship Program Director and the UH EI Residency Associate Director. His innovations in teaching include work with ORBIS/Cyber-sight, AAPOS, and the AAO, with interests in telemedicine, live webinars (first to produce national and international sessions in the field of ophthalmology), online journal clubs, and unique learning tools such as an interactive strabismus and retinoscopy simulators. He is the Editor-in-Chief for the AAO’s newly formed KTEF Pediatric Ophthalmology Education Center (the largest online educational source in the world for pediatric ophthalmology and strabismus, it has been visited more than 1 million times from more than 200 countries since its inception in 2015).

Dr. Örge’s research interests comprise almost all aspects of pediatric ophthalmology (ocular imaging, drug release, ROP, glaucoma, microsurgery, cataract, genetic conditions, eyelid trauma, consultation, sedation, strabismus, nystagmus, amblyopia, etc.) funded by NIH/NEI, KTEF Research Grant, UH TVSF Grant, CWRU Coulter Grant, Bernadet Foundation, Cleveland Foundation, Rainbow research awards, CWRU PFI Funding, Ohio Amblyope Registry, UH Innovation day, pharmaceutical/device companies (Alcon, Bausch and Lomb, Novartis, Ophthec). He holds a patent for a novel glaucoma device and also filed several patents on drug delivery, eye imaging, wound healing, and other therapeutic technologies.

Dr. Örge graduated from the University Hospitals and a separate Rainbow B&C Hospital Leadership Development Program in 2012 and 2018 and was a member of the AAO Leadership Development Program 2015 class. He currently serves as the Vice President of the International Pediatric Ophthalmology and Strabismus Council, the international supra-organization that has representatives from more than 80 countries. Through this council he is helping to align international educational efforts, and align efforts and focus on various pediatric eye disease worldwide.

Gould Syndrome Foundation